Restina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,031,598 | 1,508,745 | 651,335 | 703,776 | 1,503,911 | 1,831,881 | 2,727,117 | 319,291 |
| Profit before tax | 531,485 | 390,376 | -124,224 | 115,559 | 308,427 | 315,662 | 1,090,244 | -154,349 |
| Net profit | 448,509 | 331,968 | -124,469 | 110,330 | 262,157 | 268,208 | 926,697 | -154,349 |
| Equity | 443,582 | 775,550 | 651,081 | 761,411 | 1,023,568 | 1,291,776 | 2,218,473 | 2,062,405 |
| Liabilities | 153,731 | 104,836 | 203,779 | 39,365 | 120,281 | 307,812 | 352,256 | 2,355 |
| Non-current assets | 0 | 0 | 758 | 409 | 26,309 | 21,479 | 16,706 | 11,934 |
| Current assets | 597,313 | 880,386 | 857,457 | 800,367 | 1,117,138 | 1,577,671 | 2,553,603 | 2,063,887 |
| Total assets | 597,313 | 880,386 | 858,215 | 800,776 | 1,143,447 | 1,599,150 | 2,570,309 | 2,075,821 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 72,280 | 69,038 | 142,925 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +1214.8% | +46.3% | -56.8% | +8.1% | +113.7% | +21.8% | +48.9% | -88.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 75.1% | 37.7% | -14.5% | 13.8% | 22.9% | 16.8% | 36.1% | -7.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 101.1% | 42.8% | -19.1% | 14.5% | 25.6% | 20.8% | 41.8% | -7.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 43.5% | 22.0% | -19.1% | 15.7% | 17.4% | 14.6% | 34.0% | -48.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 51.5% | 25.9% | -19.1% | 16.4% | 20.5% | 17.2% | 40.0% | -48.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.1 | 0.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 825,278 | 1,106,443 | 651,335 | 703,776 | 1,503,911 | 1,831,881 | 2,727,117 | 319,291 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Restina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-16 | 2023-06-08 | 3.91 |
| 2022-07-25 | 2022-07-27 | 0.01 |
| 2022-06-16 | 2022-06-16 | 14.67 |
| 2022-05-17 | 2022-06-09 | 0.04 |
| 2022-04-28 | 2022-05-04 | 0.04 |
| 2022-03-16 | 2022-03-17 | 17.10 |
| 2022-02-17 | 2022-03-07 | 2.47 |
Restina - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Restina, UAB (code 303385013) is a private limited liability company operating in the wholesale of pharmaceutical and medical goods. In 2025, revenue fell to €319.3K, down 88.3% year on year and 82.6% compared with 2023. This followed a much stronger 2024, when revenue reached €2.73M, versus €1.83M in 2023. Profitability weakened sharply in 2025: the company reported a net loss of €154.3K, after net profit of €926.7K in 2024 and €268.2K in 2023. The 2025 profit margin was -48.3%, compared with 34.0% in 2024 and 14.6% in 2023. Despite the earnings decline, the balance sheet remained solidly equity financed. Total assets stood at €2.08M, equity at €2.06M, and liabilities at only €2.4K, giving an equity ratio of 99.3%. Long-term assets were €11.9K and short-term assets €2.06M. Asset turnover was 0.15x, while ROE was -7.5% and ROA -7.4%. Revenue per employee was €319.3K, with profit per employee of -€154.3K in 2025.